Shanghai, China · Founded 2020 · Privately Held (backing)
Developer of mRNA-based pharmaceutical products designed for nucleic acid-based therapeutics. Rongcan Biotech is based in Shanghai, China and was founded in 2020. It has raised $13.8 million.
Last price · $/share
—
Implied valuation
—
Total raised
$13.8M
Last round
—
Team — not yet on record
No current team members for Rongcan Biotech are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Rongcan Biotech with a free account
·Watch Rongcan Biotech: the Monday email on marks, rounds and moves
